Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of 10 Days Intravenous Milrinone Treatment to Optimize Cerebral Hemodynamic and Prevent Delayed Cerebral Ischemia (DCI) in Patients with Severe Subarachnoid Hemorrhage Due to Intracranial Aneurysm Rupture

NCT04282629 is registered in ClinicalTrials.gov with University Hospital, Toulouse as lead sponsor.

NCT NCT04282629
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04282629 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of 10 Days Intravenous Milrinone Treatment to Optimize Cerebral Hemodynamic and Prevent Delayed Cerebral Ischemia (DCI) in Patients with Severe Subarachnoid Hemorrhage Due to Intracranial Aneurysm Rupture
Lead sponsor
University Hospital, Toulouse
Phase
Phase 2
Overall status
Recruiting
Start date
July 25, 2021
Completion date
July 31, 2025
Enrollment
234 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

aneurysmal subarachnoid hemorrhage